Please use this identifier to cite or link to this item:
|Title:||Modulation of the renin-angiotensin system by atrial natriuretic peptide.|
|Authors:||Johnston, Colin I;Phillips, P A;Arnolda, L;Mooser, V|
|Affiliation:||Department of Medicine, Austin Hospital, Heidelberg, Victoria, Australia|
|Citation:||Journal of Cardiovascular Pharmacology; 16 Suppl 7(): S43-6|
|Abstract:||Many hormonal systems are involved in salt homeostasis and blood pressure control, including the renin-angiotensin-aldosterone system, the kallikrein-kinin system, and atrial and brain natriuretic peptides. Many of these hormonal peptides have actions both in the central nervous system and the periphery that are complementary. There is also increasing evidence that many of them may act as both circulating endocrine systems as well as local paracrine autocrine systems. The atrial natriuretic peptides may be viewed as endogenous inhibitors of the renin-angiotensin system. Angiotensin-converting enzyme (ACE) and renin inhibitors have provided important information on the role of the renin-angiotensin system in physiological and pathophysiologic states. The development of specific atriopeptidase inhibitors, kinin antagonists, and kallikrein inhibitors offer the same promise for these systems.|
|Internal ID Number:||1708022|
Atrial Natriuretic Factor.physiology
|Appears in Collections:||Journal articles|
Files in This Item:
There are no files associated with this item.
Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.